Michael Potter (Medic)

Michael Potter (born February 27, 1924 in East Orange , New Jersey , USA , † June 18, 2013 in Bethesda , Maryland ) was an American immunologist and cancer researcher.

Potter earned an MD from the University of Virginia in Charlottesville , Virginia in 1949 . He then did his military service as a military doctor in the US Army . In 1954 he joined Lloyd Faw in the Leukemia Research Department of the National Cancer Institute (NHI), a member of the National Institutes of Health (NIH). Between 1982 and 2003 he headed the genetics laboratory there. Thereafter, he was the line of B-cell - lymphoma of working group.

Potter's achievements lay in researching the plasma cell , the cell that produces antibodies . In 1956 he was able to show that certain mineral oil products can trigger plasma cell malignancies in mice , including plasmacytomas . These tumors can be transplanted and cultured indefinitely in vitro . These cell lines serve as models for human diseases. Other achievements included research into immunoglobulins and preparatory work on the development of the hybridoma technology for the production of monoclonal antibodies - for which César Milstein , Georges Köhler and Niels Jerne were awarded the Nobel Prize for Physiology or Medicine in 1984.

Potter was elected to the National Academy of Sciences in 1981 . He received the Paul Ehrlich and Ludwig Darmstaedter Prize in 1983 and the Albert Lasker Award for Basic Medical Research in 1984 .

Individual evidence

1. ↑ Michael Potter, award-winning NIH researcher , accessed October 13, 2013
2. ↑ NCI Cancer Bulletin August 3, 2004 at cancer.gov; Retrieved February 4, 2016
3. ^ Goethe University - laureate since 1952. In: uni-frankfurt.de. March 14, 2016, accessed January 23, 2016 . 
4. ^ Monoclonal antibody technology. In: laskerfoundation.org. Lasker Foundation, accessed June 3, 2020 .